Clinical Trials
Sponsor:
Sponsor Study ID:
Study Title:
PEDS-PLAN - Pediatric Precision Laboratory Advanced Neuroblastoma Therapy- A Study Using Molecular Guided Therapy with Induction Chemotherapy followed by a Randomized Controlled Trial of standard immunotherapy with or without DFMO followed by DFMO maintenance for Subjects with Newly Diagnosed High-Risk Neuroblastoma
NCT Number:
NCT02559778
Phase:
II
Protocol Type:
Treatment
Age Group:
Both
Disease Sites:
Brain and Nervous System
Study Objectives:
A prospective open label, multicenter study to evaluate the feasibility and acute toxicity of using molecularly guided therapy in combination with standard therapy followed by maintenance therapy with DFMO in subjects with newly diagnosed high risk neuroblastoma.
Study Documents
(MUSC NetID required for document access)